Although fibroblasts and multipotent stromal/stem cells, including adipose-derived stromal cells (ADSCs), have been extensively studied, they cannot be clearly distinguished from each other. We, therefore, investigated the cellular and molecular characteristics of ADSCs and fibroblasts. ADSCs and fibroblasts share several morphological similarities and surface markers, but were clearly found to be different types of cells. Contrary to previous reports, fibroblasts were not able to differentiate into adipocytes, osteoblasts, or chondrocytes. Polysome-bound mRNA profiling revealed that ∼1,547 genes were differentially expressed (DE) in the two cell types; the genes were related to cell adhesion, the extracellular matrix, differentiation, and proliferation. These findings were confirmed by functional analyses showing that ADSCs had a greater adhesion capacity than fibroblasts; the proliferation rate of fibroblasts was also higher than that of ADSCs. Importantly, 185 DE genes were integral to the plasma membrane and, thus, candidate markers for ADSC isolation and manipulation. We also observed that an established marker of fibroblasts and ADSCs, CD105, was overexpressed in ADSCs at both mRNA and protein levels. CD105 expression seemed to be related to differentiation capacity, at least for adipogenesis. This study shows that ADSCs and fibroblasts are distinct cell types. These findings should be taken into account when using these two cell types in basic and therapeutic studies.
Get full access to this article
View all access options for this article.
References
1.
LorenzK, SickerM, SchmelzerE, RupfT, SalvetterJ, Schulz-SiegmundM and BaderA. (2008). Multilineage differentiation potential of human dermal skin-derived fibroblasts. Exp Dermatol, 17:925–932.
2.
AltE, YanY, GehmertS, SongYH, AltmanA, GehmertS, VykoukalD and BaiX. (2011). Fibroblasts share mesenchymal phenotypes with stem cells, but lack their differentiation and colony-forming potential. Biol Cell, 103:197–208.
3.
BlasiA, MartinoC, BalducciL, SaldarelliM, SoletiA, NavoneSE, CanziL, CristiniS, InverniciG, ParatiEA and AlessandriG. (2011). Dermal fibroblasts display similar phenotypic and differentiation capacity to fat-derived mesenchymal stem cells, but differ in anti-inflammatory and angiogenic potential. Vasc Cell, 3:5
4.
BrohemCA, de CarvalhoCM, RadoskiCL, SantiFC, BaptistaMC, SwinkaBB, deAUC, de AraujoLR, GrafRM, FefermanIH and LorenciniM. (2013). Comparison between fibroblasts and mesenchymal stem cells derived from dermal and adipose tissue. Int J Cosmet Sci, 35:448–457.
5.
LysyPA, SmetsF, SibilleC, NajimiM and SokalEM. (2007). Human skin fibroblasts: From mesodermal to hepatocyte-like differentiation. Hepatology, 46:1574–1585.
6.
HuangHI, ChenSK, LingQD, ChienCC, LiuHT and ChanSH. (2010). Multilineage differentiation potential of fibroblast-like stromal cells derived from human skin. Tissue Eng Part A, 16:1491–1501.
7.
HaniffaMA, WangXN, HoltickU, RaeM, IsaacsJD, DickinsonAM, HilkensCM and CollinMP. (2007). Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J Immunol, 179:1595–1604.
8.
OsonoiM, IwanumaO, KikuchiA and AbeS. (2011). Fibroblasts have plasticity and potential utility for cell therapy. Hum Cell, 24:30–34.
9.
BaeS, AhnJH, ParkCW, SonHK, KimKS, LimNK, JeonCJ and KimH. (2009). Gene and microRNA expression signatures of human mesenchymal stromal cells in comparison to fibroblasts. Cell Tissue Res, 335:565–573.
10.
RebelattoCK, AguiarAM, MoretaoMP, SenegagliaAC, HansenP, BarchikiF, OliveiraJ, MartinsJ, KuligovskiC, et al. (2008). Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med (Maywood), 233:901–913.
11.
ShigunovP, Sotelo-SilveiraJ, KuligovskiC, de AguiarAM, RebelattoCK, MoutinhoJA, BrofmanPS, KriegerMA, GoldenbergS, et al. (2012). PUMILIO-2 is involved in the positive regulation of cellular proliferation in human adipose-derived stem cells. Stem Cells Dev, 21:217–227.
12.
TondreauT, LagneauxL, DejeneffeM, MassyM, MortierC, DelforgeA and BronD. (2004). Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation. Differentiation, 72:319–326.
13.
ZiporiD. (2004). Mesenchymal stem cells: harnessing cell plasticity to tissue and organ repair. Blood Cells Mol Dis, 33:211–215.
14.
JiangY, VaessenB, LenvikT, BlackstadM, ReyesM and VerfaillieCM. (2002). Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol, 30:896–904.
15.
MenssenA, HauplT, SittingerM, DelormeB, CharbordP and RingeJ. (2011). Differential gene expression profiling of human bone marrow-derived mesenchymal stem cells during adipogenic development. BMC Genomics, 12:461
16.
JeongJA, KoKM, BaeS, JeonCJ, KohGY and KimH. (2007). Genome-wide differential gene expression profiling of human bone marrow stromal cells. Stem Cells, 25:994–1002.
DominiciM, Le BlancK, MuellerI, Slaper-CortenbachI, MariniF, KrauseD, DeansR, KeatingA, ProckopD and HorwitzE. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8:315–317.
19.
SpangenbergL, ShigunovP, AbudAP, CofreAR, StimamiglioMA, KuligovskiC, ZychJ, SchittiniAV, CostaAD, et al. (2013). Polysome profiling shows extensive posttranscriptional regulation during human adipocyte stem cell differentiation into adipocytes. Stem Cell Res, 11:902–912.
20.
DaiM, ThompsonRC, MaherC, Contreras-GalindoR, KaplanMH, MarkovitzDM, OmennG and MengF. (2010). NGSQC: cross-platform quality analysis pipeline for deep sequencing data. BMC Genomics, 11Suppl 4:S7
21.
LiaoY, SmythGK and ShiW. (2013). The subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acid Res, 41:e108
22.
RobinsonMD, McCarthyDJ and SmythGK. (2010). edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics, 26:139–140.
23.
OlsenJV, BlagoevB, GnadF, MacekB, KumarC, MortensenP and MannM. (2006). Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell, 127:635–648.
24.
CoxJ and MannM. (2008). MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol, 26:1367–1372.
25.
CoxJ, NeuhauserN, MichalskiA, ScheltemaRA, OlsenJV and MannM. (2011). Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res, 10:1794–1805.
26.
ZychJ, StimamiglioMA, SenegagliaAC, BrofmanPR, DallagiovannaB, GoldenbergS and CorreaA. (2013). The epigenetic modifiers 5-aza-2′-deoxycytidine and trichostatin A influence adipocyte differentiation in human mesenchymal stem cells. Braz J Med Biol Res, 46:405–416.
27.
MakpolS, ZainuddinA, ChuaKH, YusofYA and NgahWZ. (2012). Gamma-tocotrienol modulation of senescence-associated gene expression prevents cellular aging in human diploid fibroblasts. Clinics (Sao Paulo), 67:135–143.
28.
KimJ, ChoiYS, LimS, YeaK, YoonJH, JunDJ, HaSH, KimJW, KimJH, et al. (2010). Comparative analysis of the secretory proteome of human adipose stromal vascular fraction cells during adipogenesis. Proteomics, 10:394–405.
29.
LennonDP, HaynesworthSE, ArmDM, BaberMA and CaplanAI. (2000). Dilution of human mesenchymal stem cells with dermal fibroblasts and the effects on in vitro and in vivo osteochondrogenesis. Dev Dyn, 219:50–62.
30.
CheungTH and RandoTA. (2013). Molecular regulation of stem cell quiescence. Nat Rev Mol Cell Biol, 14:329–340.
31.
MathieuJ and Ruohola-BakerH. (2013). Regulation of stem cell populations by microRNAs. Adv Exp Med Biol, 786:329–351.
32.
MirandaHC, HeraiRH, ThomeCH, GomesGG, PanepucciRA, OrellanaMD, CovasDT, MuotriAR, GreeneLJ and FacaVM. (2012). A quantitative proteomic and transcriptomic comparison of human mesenchymal stem cells from bone marrow and umbilical cord vein. Proteomics, 12:2607–2617.
33.
RebelattoCK, AguiarAM, SenegagliaAC, AitaCM, HansenP, BarchikiF, KuligovskiC, OlandoskiM, MoutinhoJA, et al (2009). Expression of cardiac function genes in adult stem cells is increased by treatment with nitric oxide agents. Biochem Biophys Res Commun, 378:456–461.
34.
MiyamotoT, IwasakiH, ReizisB, YeM, GrafT, WeissmanIL and AkashiK. (2002). Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Dev Cell, 3:137–147.
DavidsonLA, WangN, IvanovI, GoldsbyJ, LuptonJR and ChapkinRS. (2009). Identification of actively translated mRNA transcripts in a rat model of early-stage colon carcinogenesis. Cancer Prev Res (Phila), 2:984–994.
37.
ThomasJD and JohannesGJ. (2007). Identification of mRNAs that continue to associate with polysomes during hypoxia. RNA, 13:1116–1131.
38.
BolontradeMF, SgangaL, PiaggioE, VialeDL, SorrentinoMA, RobinsonA, SevleverG, GarciaMG, MazzoliniG and PodhajcerOL. (2012). A specific subpopulation of mesenchymal stromal cell carriers overrides melanoma resistance to an oncolytic adenovirus. Stem Cells Dev, 21:2689–2702.
39.
JaagerK, IslamS, ZajacP, LinnarssonS and NeumanT. (2012). RNA-seq analysis reveals different dynamics of differentiation of human dermis- and adipose-derived stromal stem cells. PLoS One, 7:e38833
40.
NajarM, RaicevicG, JebbawiF, De BruynC, MeulemanN, BronD, ToungouzM and LagneauxL. (2012). Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes. Immunol Lett, 146:50–56.
41.
PietilaM, LehtonenS, TuovinenE, LahteenmakiK, LaitinenS, LeskelaHV, NatynkiA, PesalaJ, NordstromK and LehenkariP. (2012). CD200 positive human mesenchymal stem cells suppress TNF-alpha secretion from CD200 receptor positive macrophage-like cells. PLoS One, 7:e31671
42.
CheifetzS, BellonT, CalesC, VeraS, BernabeuC, MassagueJ and LetarteM. (1992). Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem, 267:19027-19030.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
